Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01643265
Other study ID # MTI2012-CS02
Secondary ID
Status Completed
Phase N/A
First received July 16, 2012
Last updated February 13, 2013
Start date July 2012
Est. completion date September 2012

Study information

Verified date February 2013
Source Metabolic Technologies Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study will allow us to examine how quickly and to what extent plasma amino acids levels rise after ingesting a single dose of either whey or albumin protein. The investigators anticipate that the amino acids from albumin concentrate protein will rise as quickly and to the same extent as amino acids from whey protein. These findings will help us to understand the biological availability of these proteins and efficacy of the supplement so that consumers may be presented with nutritional options.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date September 2012
Est. primary completion date August 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- normal Healthy volunteers

- free of serious illness/disease such as hypertension, kidney or liver disease

Exclusion Criteria:

- taking dietary protein or amino acid supplements

Study Design

Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Whey Milk Protein
20 grams of Whey Milk Protein
Bovine Albumin Concentrate
20 grams of Bovine Albumin Concentrate

Locations

Country Name City State
United States Iowa State University Ames Iowa

Sponsors (1)

Lead Sponsor Collaborator
Metabolic Technologies Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amino acid concentration 210 minutes No
See also
  Status Clinical Trial Phase
Completed NCT01706653 - The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health N/A
Completed NCT02799498 - Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection Phase 1
Completed NCT03202654 - Effects of Corn and Coconut Oils on Lipoprotein Lipids, Insulin Sensitivity and Inflammation N/A
Completed NCT02179931 - Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®) Phase 1
Completed NCT03995602 - The Effects of Dragon Fruit Consumption on Vascular Function. N/A
Completed NCT04095949 - Absorption, Metabolism and Excretion of Artichoke Polyphenols in Healthy Individuals N/A
Completed NCT03553225 - Randomized, Double-blind, Controlled Study to Evaluate the Effect of Concord Grape Extract on Vascular Function in Healthy Men and Women N/A
Completed NCT04276974 - Effects of an Organic Plant-rich Diet on Gut Microbiome and Vascular Function (ORGAMIC Pilot Study) N/A
Completed NCT01836887 - The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health(2) N/A
Active, not recruiting NCT05058157 - Ketone Plasma Kinetics After Oral Intake of Different Ketogenic Formulae N/A
Completed NCT02588534 - Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects Phase 1
Completed NCT03485716 - Metabolic Dynamics During Physical Activity N/A